Botanical species · safety record

Merremia dissecta

The EFSA Compendium of Botanicals holds 8 constituent measurements for Merremia dissecta. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Merremia dissecta (Jacq.) Hallier f.

8Constituent measurements

0Safety records

4Cited sources

0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Alkaloids	Roots and other underground parts	Solvent extraction	—	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	Resolve DOI
Amygdalin	Seed	Solvent extraction	—	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	Resolve DOI
Cyanide	Seed	Solvent extraction	10 Millimole/kilogram	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	Resolve DOI
Cyanogenic glycosides	Leaves	—	—	Unspecified	Resolve DOI
P-coumaric acid	Seed	Solvent extraction	—	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	Resolve DOI
Prunasin	Leaves	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Tropane alkaloids	Roots and other underground parts	Solvent extraction	—	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	Resolve DOI
Calystegine b2	Aerial part of plants	Solvent extraction	—	GC-MS	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

NAHRSTEDT, A., SATTAR, EA., ELZALABANI, SMH. AMYGDALIN ACYL DERIVATIVES, CYANOGENIC GLYCOSIDES FROM THE SEEDS OF MERREMIA-DISSECTA. PHYTOCHEMISTRY, 1990, vol. 29, no. 4, p. 1179-1181. DOI
NAHRSTEDT, A., JENSEN, PS., WRAY, V. PRUNASIN-6'-MALONATE, A CYANOGENIC GLUCOSIDE FROM MERREMIA-DISSECTA. PHYTOCHEMISTRY, 1989, vol. 28, no. 2, p. 623-624. DOI
Jenett-Siems, K., Weigl, R., Bohm, A., Mann, P., Tofern-Reblin, B., Ott, SC., Ghomian, A., Kaloga, M., Siems, K., Witte, L., Hilker, M., Muller, F., Eich, E. Chemotaxonomy of the pantropical genus Merremia (Convolvulaceae) based on the distribution of tropane alkaloids. PHYTOCHEMISTRY, 2005, vol. 66, no. 12, p. 1448-1464. DOI
Schimming, Thomas., Jenett-Siems, Kristina., Mann, Petra., Tofern-Reblin, Britta., Milson, Jenny., Johnson, Robert W., Deroin, Thierry., Austin, Daniel F., Eich, Eckart. Calystegines as chemotaxonomic markers in the Convolvulaceae. Phytochemistry (Elsevier), 2005, p. 469-480.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature